Srb Corp Abb Vie Inc. Transaction History

Srb Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $92,550 - $106,585	-640 Reduced 21.07%	2,398 $382,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $946,046 - $1.09 Million	-7,049 Reduced 69.88%	3,038 $408,000
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $253,220 - $321,926	-1,840 Reduced 15.43%	10,087 $1.55 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $250,204 - $316,580	-2,329 Reduced 16.34%	11,927 $1.62 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1.52 Million - $1.72 Million	14,256 New	14,256 $1.54 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $466,663 - $547,708	-5,432 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $17,608 - $23,563	-240 Reduced 4.23%	5,432 $533,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $365,844 - $554,664	5,672 New	5,672 $432,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $380,903 - $457,954	-6,048 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $397,353 - $507,911	6,048 New	6,048 $440,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $483,127 - $568,617	-6,263 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $487,574 - $601,310	6,263 New	6,263 $577,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.